Racial and age-related disparities in early mortality affect the outcomes of multiple myeloma patients.
作者信息
Covut Fahrettin, Driscoll James Joseph, Cooper Brenda, Gallogly Molly, De Lima Marcos, Malek Ehsan
机构信息
Adult Hematologic Malignancies & Stem Cell Transplant Section, Seidman Cancer Center, University Hospitals Cleveland Medical Center, Cleveland, OH, USA.
Case Western Reserve University, Cleveland, OH, USA.
出版信息
Leukemia. 2021 Jan;35(1):250-254. doi: 10.1038/s41375-020-0812-2. Epub 2020 May 24.
Abstract
摘要
相似文献
1
Racial and age-related disparities in early mortality affect the outcomes of multiple myeloma patients.早期死亡率方面与种族和年龄相关的差异会影响多发性骨髓瘤患者的治疗结果。
Leukemia. 2021 Jan;35(1):250-254. doi: 10.1038/s41375-020-0812-2. Epub 2020 May 24.
2
Racial disparities in hospitalization outcomes among adult multiple myeloma patients using the national inpatient sample (2016-2018).利用国家住院患者样本（2016 - 2018年）对成年多发性骨髓瘤患者住院结局的种族差异研究
Hematol Oncol. 2021 Dec;39(5):724-727. doi: 10.1002/hon.2907. Epub 2021 Aug 7.
3
Disease and outcome disparities in multiple myeloma: exploring the role of race/ethnicity in the Cooperative Group clinical trials.多发性骨髓瘤的疾病和结局差异：探索种族/民族在合作组临床试验中的作用。
Blood Cancer J. 2018 Jul 6;8(7):67. doi: 10.1038/s41408-018-0102-7.
4
Many Shades of Disparities in Myeloma Care.骨髓瘤治疗中差异的多种表现形式
Am Soc Clin Oncol Educ Book. 2019 Jan;39:519-529. doi: 10.1200/EDBK_238551. Epub 2019 May 17.
5
Age-related health care disparities in multiple myeloma.多发性骨髓瘤中与年龄相关的医疗保健差异。
Hematol Oncol. 2018 Feb;36(1):224-231. doi: 10.1002/hon.2422. Epub 2017 Apr 21.
6
Addressing the disparities: the approach to the African American patient with multiple myeloma.解决差异问题：多发性骨髓瘤非裔美国患者的处理方法。
Blood Cancer J. 2023 Dec 18;13(1):189. doi: 10.1038/s41408-023-00961-0.
7
Changes in treatment landscape of relapsed or refractory multiple myeloma and their association with mortality: Insights from German claims database.复发或难治性多发性骨髓瘤治疗格局的变化及其与死亡率的关联：来自德国索赔数据库的见解
Eur J Haematol. 2021 Feb;106(2):148-157. doi: 10.1111/ejh.13523. Epub 2020 Nov 20.
8
Trends in multiple myeloma presentation, management, cost of care, and outcomes in the Medicare population: A comprehensive look at racial disparities.在 Medicare 人群中，多发性骨髓瘤的表现、治疗、护理费用和结果的趋势：全面了解种族差异。
Cancer. 2018 Apr 15;124(8):1710-1721. doi: 10.1002/cncr.31237. Epub 2018 Jan 23.
9
Equal Treatment and Outcomes for Everyone with Multiple Myeloma: Are We There Yet?多发性骨髓瘤患者人人享有平等治疗与结局：我们做到了吗？
Curr Hematol Malig Rep. 2017 Aug;12(4):309-316. doi: 10.1007/s11899-017-0393-y.
10
Racial disparities in multiple myeloma and access to stem cell transplantation.多发性骨髓瘤中的种族差异与干细胞移植的可及性
Blood Cancer J. 2024 Jul 22;14(1):120. doi: 10.1038/s41408-024-01097-5.
引用本文的文献
1
Racial and Ethnic Disparity for Cancer Mortality in General and Single-Payer Healthcare Systems in the United States.美国全民医保和单支付者医保体系中癌症死亡率的种族和族裔差异
J Racial Ethn Health Disparities. 2024 Jul 2. doi: 10.1007/s40615-024-02077-y.
2
Disparities in Multiple Myeloma Treatment Patterns in the United States: A Systematic Review.美国多发性骨髓瘤治疗模式的差异：系统评价。
Clin Lymphoma Myeloma Leuk. 2023 Nov;23(11):e420-e427. doi: 10.1016/j.clml.2023.08.008. Epub 2023 Aug 13.
3
A real-world data analysis of predictors of early mortality after a diagnosis of multiple myeloma.多发性骨髓瘤诊断后早期死亡预测因素的真实世界数据分析。
Cancer. 2023 Jul 1;129(13):2023-2034. doi: 10.1002/cncr.34760. Epub 2023 Mar 29.
4
Cardiovascular Toxicity of Proteasome Inhibitors: Underlying Mechanisms and Management Strategies: State-of-the-Art Review.蛋白酶体抑制剂的心血管毒性：潜在机制与管理策略：最新综述
JACC CardioOncol. 2023 Feb 21;5(1):1-21. doi: 10.1016/j.jaccao.2022.12.005. eCollection 2023 Feb.
5
Editorial: Epidemiological trends in hematological malignancies.社论：血液系统恶性肿瘤的流行病学趋势
Front Oncol. 2023 Feb 14;13:1151774. doi: 10.3389/fonc.2023.1151774. eCollection 2023.
本文引用的文献
1
Racial differences in bone strength.骨强度的种族差异。
Trans Am Clin Climatol Assoc. 2007;118:305-15.
Zotero 插件